Bekaii-Saab T - Search Results

1

A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.

Ahn DH, Uson Junior PLS, Masci P, Kosiorek H, Halfdanarson TR, Mody K, Babiker H, DeLeon T, Sonbol MB, Gores G, Smoot R, Bekaii-Saab T, Mahipal A, Mansfield A, Tran NH, Hubbard JM, Borad MJ. Ahn DH, et al. Invest New Drugs. 2022 Feb;40(1):134-141. doi: 10.1007/s10637-021-01170-x. Epub 2021 Aug 31. Invest New Drugs. 2022. PMID: 34463891 Clinical Trial.

2

A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC).

Bekaii-Saab TS, Mortazavi A, Hicks LG, Zalupski M, Pelley RJ, Chan KK, Kraut EH. Bekaii-Saab TS, et al. Invest New Drugs. 2006 Jul;24(4):343-6. doi: 10.1007/s10637-005-4827-3. Invest New Drugs. 2006. PMID: 16446986 Free article. Clinical Trial.

3

Phase II trial of pyrazoloacridine (NSC#366140) in patients with metastatic breast cancer.

Ramaswamy B, Mrozek E, Kuebler JP, Bekaii-Saab T, Kraut EH. Ramaswamy B, et al. Invest New Drugs. 2011 Apr;29(2):347-51. doi: 10.1007/s10637-009-9338-1. Epub 2009 Oct 21. Invest New Drugs. 2011. PMID: 19844661 Free PMC article. Clinical Trial.

4

A phase I study of topotecan and gemcitabine in advanced solid tumors.

Serna DS, Bekaii-Saab T, Kraut EH. Serna DS, et al. Invest New Drugs. 2011 Dec;29(6):1390-4. doi: 10.1007/s10637-010-9480-9. Epub 2010 Jun 25. Invest New Drugs. 2011. PMID: 20574789 Clinical Trial.

5

Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients.

Rubinson DA, Hochster HS, Ryan DP, Wolpin BM, McCleary NJ, Abrams TA, Chan JA, Iqbal S, Lenz HJ, Lim D, Rose J, Bekaii-Saab T, Chen HX, Fuchs CS, Ng K. Rubinson DA, et al. Invest New Drugs. 2014 Feb;32(1):113-22. doi: 10.1007/s10637-013-9956-5. Epub 2013 Apr 9. Invest New Drugs. 2014. PMID: 23568716 Free PMC article. Clinical Trial.

6

Ampullary cancer: an overview.

Ahn DH, Bekaii-Saab T. Ahn DH, et al. Am Soc Clin Oncol Educ Book. 2014:112-5. doi: 10.14694/EdBook_AM.2014.34.112. Am Soc Clin Oncol Educ Book. 2014. PMID: 24857067 Free PMC article. Review.

7

A phase II trial of bevacizumab plus temsirolimus in patients with advanced hepatocellular carcinoma.

Knox JJ, Qin R, Strosberg JR, Tan B, Kaubisch A, El-Khoueiry AB, Bekaii-Saab TS, Rousey SR, Chen HX, Erlichman C. Knox JJ, et al. Invest New Drugs. 2015 Feb;33(1):241-6. doi: 10.1007/s10637-014-0169-3. Epub 2014 Oct 16. Invest New Drugs. 2015. PMID: 25318437 Clinical Trial.

8

The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.

Ahn DH, Wu C, Wei L, Williams TM, Wuthrick E, Abdel-Misih S, Harzman A, Husain S, Schmidt C, Goldberg RM, Bekaii-Saab T. Ahn DH, et al. Am J Clin Oncol. 2017 Dec;40(6):531-534. doi: 10.1097/COC.0000000000000185. Am J Clin Oncol. 2017. PMID: 25723741 Free PMC article.

9

Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.

Ahn DH, Ko AH, Meropol NJ, Bekaii-Saab TS. Ahn DH, et al. Am Soc Clin Oncol Educ Book. 2015:e222-7. doi: 10.14694/EdBook_AM.2015.35.e222. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993177 Free PMC article. Review.

10

Results of an abbreviated phase-II study with the Akt Inhibitor MK-2206 in Patients with Advanced Biliary Cancer.

Ahn DH, Li J, Wei L, Doyle A, Marshall JL, Schaaf LJ, Phelps MA, Villalona-Calero MA, Bekaii-Saab T. Ahn DH, et al. Sci Rep. 2015 Jul 10;5:12122. doi: 10.1038/srep12122. Sci Rep. 2015. PMID: 26161813 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

391 results

Search Page

Filters